Compliance with Psychedelics and Emerging Therapies
-
Debbie Casey, Partner.
Kelly Willenberg, CEO, Kelly Willenberg and Associates.
Linda Iovanni, Director, Clinical Operations.
2023-11-09
-
Discussion of emerging therapies including clinical trials and the future of psychotherapy
-
Discussion of steps that can be taken to mitigate risk and increase protective factors for the subjects
-
Review of integration techniques, resources, legal and ethical issues with these emerging therapies
THIS DOCUMENT IS ONLY AVAILABLE TO MEMBERS OR ATTENDEES. PLEASE LOG IN OR PURCHASE ACCESS.
THIS RECORDING IS ONLY AVAILABLE TO ATTENDEES AND PURCHASERS. PLEASE LOG IN OR PURCHASE ACCESS.